Literature DB >> 15465833

Aldose reductase-catalyzed reduction of aldehyde phospholipids.

Sanjay Srivastava1, Matthew Spite, John O Trent, Matthew B West, Yonis Ahmed, Aruni Bhatnagar.   

Abstract

Oxidation of unsaturated phospholipids results in the generation of aldehyde side chains that remain esterified to the phospholipid backbone. Such "core" aldehydes elicit immune responses and promote inflammation. However, the biochemical mechanisms by which phospholipid aldehydes are metabolized or detoxified are not well understood. In the studies reported here, we examined whether aldose reductase (AR), which reduces hydrophobic aldehydes, metabolizes phospholipid aldehydes. Incubation with AR led to the reduction of 5-oxovaleroyl, 7-oxo-5-heptenoyl, 5-hydroxy-6-oxo-caproyl, and 5-hydroxy-8-oxo-6-octenoyl phospholipids generated upon oxidation of 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine (PAPC). The enzyme also catalyzed the reduction of phospholipid aldehydes generated from the oxidation of 1-alkyl, and 1-alkenyl analogs of PAPC, and 1-palmitoyl-2-arachidonoyl phosphatidic acid or phosphoglycerol. Aldose reductase catalyzed the reduction of chemically synthesized 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphatidylcholine (POVPC) with a K(m) of 10 mum. Addition of POVPC to the culture medium led to incorporation and reduction of the aldehyde in COS-7 and THP-1 cells. Reduction of POVPC in these cells was prevented by the AR inhibitors sorbinil and tolrestat and was increased in COS-7 cells overexpressing AR. Together, these observations suggest that AR may be a significant participant in the metabolism of several structurally diverse phospholipid aldehydes. This metabolism may be a critical regulator of the pro-inflammatory and immunogenic effects of oxidized phospholipids.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15465833      PMCID: PMC3475326          DOI: 10.1074/jbc.M403416200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  76 in total

Review 1.  Molecular and cellular mechanisms of myocardial stunning.

Authors:  R Bolli; E Marbán
Journal:  Physiol Rev       Date:  1999-04       Impact factor: 37.312

2.  Structural and kinetic determinants of aldehyde reduction by aldose reductase.

Authors:  S Srivastava; S J Watowich; J M Petrash; S K Srivastava; A Bhatnagar
Journal:  Biochemistry       Date:  1999-01-05       Impact factor: 3.162

3.  Metabolism of the lipid peroxidation product, 4-hydroxy-trans-2-nonenal, in isolated perfused rat heart.

Authors:  S Srivastava; A Chandra; L F Wang; W E Seifert; B B DaGue; N H Ansari; S K Srivastava; A Bhatnagar
Journal:  J Biol Chem       Date:  1998-05-01       Impact factor: 5.157

Review 4.  Mechanisms for oxidizing low-density lipoprotein. Insights from patterns of oxidation products in the artery wall and from mouse models of atherosclerosis.

Authors:  J P Gaut; J W Heinecke
Journal:  Trends Cardiovasc Med       Date:  2001 Apr-May       Impact factor: 6.677

Review 5.  Oxidized LDL contains inflammatory PAF-like phospholipids.

Authors:  G K Marathe; S M Prescott; G A Zimmerman; T M McIntyre
Journal:  Trends Cardiovasc Med       Date:  2001 Apr-May       Impact factor: 6.677

Review 6.  Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 1.

Authors:  R A Kloner; R B Jennings
Journal:  Circulation       Date:  2001-12-11       Impact factor: 29.690

7.  Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis.

Authors:  H L Rittner; V Hafner; P A Klimiuk; L I Szweda; J J Goronzy; C M Weyand
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

8.  Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice.

Authors:  R Quarck; B De Geest; D Stengel; A Mertens; M Lox; G Theilmeier; C Michiels; M Raes; H Bult; D Collen; P Van Veldhoven; E Ninio; P Holvoet
Journal:  Circulation       Date:  2001-05-22       Impact factor: 29.690

9.  Structural and kinetic modifications of aldose reductase by S-nitrosothiols.

Authors:  S Srivastava; B L Dixit; K V Ramana; A Chandra; D Chandra; A Zacarias; J M Petrash; A Bhatnagar; S K Srivastava
Journal:  Biochem J       Date:  2001-08-15       Impact factor: 3.857

10.  The reactive oxygen species--and Michael acceptor-inducible human aldo-keto reductase AKR1C1 reduces the alpha,beta-unsaturated aldehyde 4-hydroxy-2-nonenal to 1,4-dihydroxy-2-nonene.

Authors:  M E Burczynski; G R Sridhar; N T Palackal; T M Penning
Journal:  J Biol Chem       Date:  2000-11-01       Impact factor: 5.157

View more
  28 in total

1.  Human aldose reductase expression accelerates atherosclerosis in diabetic apolipoprotein E-/- mice.

Authors:  Srinivasan Vedantham; HyeLim Noh; Radha Ananthakrishnan; Ni Son; Kellie Hallam; Yunying Hu; Shuiquing Yu; Xiaoping Shen; Rosa Rosario; Yan Lu; Thyyar Ravindranath; Konstantinos Drosatos; Lesley Ann Huggins; Ann Marie Schmidt; Ira J Goldberg; Ravichandran Ramasamy
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-06-02       Impact factor: 8.311

2.  Aldose reductase regulates TNF-α-induced inducible nitric oxide synthase expression in human mesangial cells.

Authors:  Jingjing Zhao; Tao Jiang; Hui Li; Yuejuan Zhang; Nong Zhang
Journal:  Mol Biol Rep       Date:  2011-06-03       Impact factor: 2.316

3.  Functional expression of novel human and murine AKR1B genes.

Authors:  Joshua K Salabei; Xiao-Ping Li; J Mark Petrash; Aruni Bhatnagar; Oleg A Barski
Journal:  Chem Biol Interact       Date:  2011-01-27       Impact factor: 5.192

4.  Reductive metabolism increases the proinflammatory activity of aldehyde phospholipids.

Authors:  Elena Vladykovskaya; Evgeny Ozhegov; J David Hoetker; Zhengzhi Xie; Yonis Ahmed; Jill Suttles; Sanjay Srivastava; Aruni Bhatnagar; Oleg A Barski
Journal:  J Lipid Res       Date:  2011-09-27       Impact factor: 5.922

Review 5.  A potential therapeutic role for aldose reductase inhibitors in the treatment of endotoxin-related inflammatory diseases.

Authors:  Saumya Pandey; Satish K Srivastava; Kota V Ramana
Journal:  Expert Opin Investig Drugs       Date:  2012-01-28       Impact factor: 6.206

6.  Selective enzymatic reduction of aldehydes.

Authors:  Guido Sello; Fulvia Orsini; Silvana Bernasconi; Patrizia Di Gennaro
Journal:  Molecules       Date:  2006-05-12       Impact factor: 4.411

7.  Aldose reductase decreases endoplasmic reticulum stress in ischemic hearts.

Authors:  Rachel J Keith; Petra Haberzettl; Elena Vladykovskaya; Bradford G Hill; Karin Kaiserova; Sanjay Srivastava; Oleg Barski; Aruni Bhatnagar
Journal:  Chem Biol Interact       Date:  2008-11-11       Impact factor: 5.192

Review 8.  The aldo-keto reductase superfamily and its role in drug metabolism and detoxification.

Authors:  Oleg A Barski; Srinivas M Tipparaju; Aruni Bhatnagar
Journal:  Drug Metab Rev       Date:  2008       Impact factor: 4.518

9.  Catalytic mechanism and substrate specificity of the beta-subunit of the voltage-gated potassium channel.

Authors:  Srinivas M Tipparaju; Oleg A Barski; Sanjay Srivastava; Aruni Bhatnagar
Journal:  Biochemistry       Date:  2008-08-02       Impact factor: 3.162

10.  Reductive metabolism of AGE precursors: a metabolic route for preventing AGE accumulation in cardiovascular tissue.

Authors:  Shahid P Baba; Oleg A Barski; Yonis Ahmed; Timothy E O'Toole; Daniel J Conklin; Aruni Bhatnagar; Sanjay Srivastava
Journal:  Diabetes       Date:  2009-08-03       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.